June 06, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
NEW ORLEANS — A next-generation automated insulin delivery algorithm was tied to improved glycemic outcomes compared with a currently available system, according to data presented at the American Diabetes Association Scientific Sessions.In the STRIVE trial, researchers assessed glycemic outcomes, insulin delivery and device usage among people with type 1 or type 2 diabetes using the
June 06, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes

Triple hormone receptors, a monthly obesity drug, and a bittersweet ending

Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring

ADA: Amgen highlights Repatha perks, GLP-1 pitfalls in push to boost cardiometabolic pedigree

NEW ORLEANS — Adults with type 2 diabetes achieved higher time in range with the next-generation Omnipod 6 automated insulin…

NEW ORLEANS —Use of automated insulin delivery during hospitalization may improve glycemic outcomes for adults with…

NEW ORLEANS — In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and…

NEW ORLEANS — Adults with type 1 diabetes had a similar time in range using automated insulin delivery with ultrarapid-acting…

Youths who start using an automated insulin delivery system within 6 months of type 1 diabetes diagnosis are 82% more likely to…

Children and adults with type 1 diabetes who used a fast-acting mealtime insulin along with automated insulin delivery had…